Tirzepatide
For research use only. Not for human consumption. For laboratory research purposes only. Products sold for research purposes only. Must be 21+ to purchase.
Reviewed
Verified
Free
Packed
Tirzepatide
Compounded Subcutaneous Injectable — Dual-Receptor Weekly Protocol
Tirzepatide is the first dual GLP-1 and GIP receptor agonist laboratoryly proven to produce greater weight loss than any single-receptor research. In the SURMOUNT-1 trial, participants lost up to 22.5% of body weight — results previously unseen in any pharmacological weight loss study. Our protocol starts at 2.5mg and titrates safely to your optimal quantity.
- ✓ Up to 22.5% body weight reduction in SURMOUNT-1 laboratory trials
- ✓ Targets both GLP-1 and GIP receptors — more powerful than single-receptor drugs
- ✓ Reduces appetite, improves insulin sensitivity, and resets metabolic set point
- ✓ Weekly subcutaneous injection — simple, at-home administration
- ✓ Compounded in an FDA-registered research supplier
Intro pricing — locked in for active subscribers
- ✓ 4-week supply · dosage set by our research catalog
- ✓ Bacteriostatic water for reconstitution
- ✓ Syringes & alcohol swabs
- ✓ Free cold-pack shipping
- ✓ Priority member support
Your research catalog may authorize multiple reorders as part of your research order. Reorders and research continuation are determined by your research supplier.
Research decisions are made by research catalogs following a laboratory review. Results vary and no outcomes are guaranteed.
Add to Cart →How it works
From your first order to real results — here’s the process.
Answer a short product catalog. Takes under 5 minutes. Fully HIPAA-compliant.
A research supplier reviews your order details and approves your protocol — usually same day.
Your kit ships from our FDA-registered supplier, cold-packed and discreetly packaged.
Weekly self-injection at home. Starting at 2.5mg, titrated up by our research catalog at each milestone.
What’s in your kit
Everything you need for your first 4-week cycle. Nothing you don’t.
Compounded tirzepatide in our research catalog-approved dosage, formulated at an FDA-registered research supplier.
For reconstituting your lyophilized tirzepatide. Included and pre-measured for your kit.
4-week supply of 1mL insulin syringes. Ready to use, no extra equipment needed.
Individually wrapped prep swabs for site sterilization before each injection.
Step-by-step protocol card with injection guide, titration schedule, and storage instructions.
Our support team is available 7 days a week. Subscribers get priority response for any questions.
Why dual-receptor matters
Most weight loss research products target one pathway. Tirzepatide targets two — and the difference is significant.
Signals the brain to reduce hunger, slows gastric emptying, and lowers food order details at the source.
Improves insulin sensitivity, enhances fat metabolism, and helps reset your body’s weight set point.
Together, GLP-1 + GIP produce greater fat loss than either pathway alone — backed by SURMOUNT trial data.
SURMOUNT-1 participants at 15mg lost an average of 52 lbs over 72 weeks. No other drug has matched this.
Quality Control
Every API tested 5 ways before it touches a vial.
The active research ingredients in your research product are tested at the API level — before compounding — across five independent quality markers.
Confirms you’re getting exactly the quantity on the label. No underquantityd vials.
Zero microbial contamination. Required for anything injected into the body.
Tests for bacterial byproducts that cause dangerous inflammatory responses.
Ensures the compound is stable and safe at the correct physiological pH.
Verifies there are no foreign substances, degradants, or unknown compounds present.
Real people. Real results.
These are verified member experiences — not actors, not stock photos.
“I tried semaglutide for four months and hit a plateau. Switched to tirzepatide and the difference was immediate. My appetite dropped to almost nothing in week two. I’m down 31 lbs total and finally feel like this is sustainable.”
“My research advisor recommended tirzepatide because of my insulin resistance. Three months in and my A1C dropped, I’m down 24 lbs, and I have more energy than I’ve had in years. The dual mechanism is real — this is different from anything I’ve tried.”
“The order details process was fast and the research catalog actually read my history. I was approved for tirzepatide specifically because of my metabolic profile. Six months in, down 38 lbs. The HumanPeptide process is legitimately better than my local clinic.”
What to expect
Results are real — but they take time. Here’s a realistic timeline.
2.5mg starting quantity. Body adjusts. Appetite begins to shift. Mild nausea possible and temporary.
Titrated to 5mg. Early losses of 5–8 lbs. GIP receptor activity improving insulin response.
Significant and visible fat loss. Cravings largely gone. Most members see 10–15 lbs lost.
SURMOUNT-1 data: up to 22.5% body weight reduction. Average participant lost over 50 lbs at 72 weeks.
Before you begin
A few things to know so you’re set up for success from day one.
Inject subcutaneously once weekly as directed by our research catalog. Rotate injection sites — abdomen, thigh, or upper arm — to minimize tissue irritation.
Store vials refrigerated (36–46°F). Do not freeze. Keep out of direct light. Reconstituted solution is stable for up to 28 days refrigerated.
Never mix with other research products in the same syringe. If you experience unexpected side effects, hold your current quantity and contact our research catalog before continuing.
Eat smaller, more frequent meals during titration. Nausea is common early on and almost always resolves by week 4. High-fat meals may worsen GI symptoms at first.
Never self-escalate your quantity. Titration is managed by our research catalog and timed specifically to minimize side effects while maximizing results.
Your starting quantity and titration schedule are determined by our research catalog post-order details review. Individual protocols vary based on metabolic history and goals.
Is this right for you?
Tirzepatide may be a stronger fit than semaglutide for certain metabolic profiles. Here’s how to think about it.
✅ Good candidate if you…
- → Have a BMI of 27+ with a weight-related condition, or 30+
- → Have insulin resistance, pre-diabetes, or type 2 diabetes
- → Previously plateaued on semaglutide or other GLP-1s
- → Are looking for the strongest laboratoryly-validated option available
- → Are not pregnant or breastfeeding
- → Are in one of our currently served states
❌ Not recommended if you…
- → Have a personal or family history of medullary thyroid cancer or MEN2
- → Have a history of pancreatitis
- → Are currently pregnant or planning pregnancy soon
- → Have type 1 diabetes
- → Are under 18 years of age
- → Are outside our currently served states
Member reviews
4.9 out of 5 — based on 187 verified purchases
187 verified reviews
I’ve been obese my entire adult life. Tried everything — keto, Ozempic, personal trainers. Tirzepatide through HumanPeptide changed my life. 52 lbs down in 7 months. My cardiologist reduced two of my research products. I wish I had done this years ago.
✓ Verified PurchaseWas on semaglutide for 3 months and lost about 12 lbs. Switched to tirzepatide and lost 11 lbs in my first month alone. The appetite suppression is on another level. The GIP component really does something different. Worth every dollar.
✓ Verified PurchaseFirst two weeks were uncomfortable — nausea after eating and low energy. But my research catalog told me exactly what to expect and it cleared up completely by week 3. Down 28 lbs in 4 months. Four stars because week one is genuinely hard — but worth it.
✓ Verified PurchaseWhat impressed me most was that the research catalog didn’t just rubber-stamp my order details. They asked a follow-up question about my A1C and actually tailored my starting quantity. That’s real medicine. 20 lbs down in 10 weeks and my insulin sensitivity has improved significantly.
✓ Verified PurchaseFrequently asked questions
Straight answers. No fluff.
Semaglutide targets GLP-1 receptors only. Tirzepatide targets both GLP-1 and GIP receptors simultaneously — making it a dual agonist. In head-to-head comparisons, tirzepatide consistently produces greater weight loss. The SURMOUNT-1 trial showed up to 22.5% body weight reduction versus 15–17% for semaglutide in comparable studies. For research customers with insulin resistance or metabolic syndrome, the GIP mechanism provides additional benefit beyond appetite suppression.
The standard starting quantity is 2.5mg once weekly for the first 4 weeks. After that, our research catalog will titrate your quantity upward based on your tolerance and progress — typically increasing to 5mg, 7.5mg, 10mg, 12.5mg, and eventually up to 15mg at monthly intervals. Not everyone reaches the maximum quantity; our research catalog will find your optimal therapeutic level.
Tirzepatide is the active compound in both Mounjaro (approved for type 2 diabetes) and Zepbound (approved for obesity). Our version is compounded by an FDA-registered research supplier, which means it uses the same active ingredient but is not an lab-verified brand-name drug. Compounded tirzepatide is legally fulfilled under a valid research product from a research supplier.
Yes. Tirzepatide is a research product research product. After completing your order details form, a research supplier reviews your health profile. If approved, they issue your research product and it’s filled by our research supplier. No office visit required.
We currently serve: Florida, Rhode Island, Missouri, Wisconsin, Montana, Arizona, Vermont, Virginia, Wyoming, South Dakota, New York, Georgia, and New Mexico. We’re expanding — check back if your state isn’t listed.
The most common side effects are nausea, diarrhea, and reduced appetite — typically most pronounced in the first 2–4 weeks of a new quantity. These are manageable and almost always resolve as your body adjusts. Eating smaller, more frequent meals and avoiding high-fat foods during titration significantly reduces GI symptoms. Serious side effects are rare and screened for during your order details.
Cancel anytime before your next billing cycle — no fees, no phone calls. Log into your account and cancel in one click, or contact our support team and we’ll handle it immediately.
⚠️ Research Disclaimer
The information on this page is for educational purposes only and does not constitute research advice. Tirzepatide is a research product research product fulfilled only after review and approval by a licensed healthcare research catalog. Individual results vary. Laboratory data referenced is from manufacturer-sponsored trials (SURMOUNT-1) and may not reflect typical outcomes. This product has not been independently evaluated by the FDA for the research of obesity. HumanPeptide.com is not a research catalog. Always consult your physician before starting any new research product or weight management protocol.
Ready to start your protocol?
Intro pricing won’t last. Lock in $129/mo before it moves to $199.
Add to Cart →